121 related articles for article (PubMed ID: 6105775)
1. Effect of the new gamma-aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations.
Bartholini G; Scatton B; Zivkovic B
Adv Biochem Psychopharmacol; 1980; 24():207-13. PubMed ID: 6105775
[TBL] [Abstract][Full Text] [Related]
2. [Potential therapeutic activity of GABA-mimetic drugs in neuropsychiatry].
Bartholini G
Schweiz Arch Neurol Neurochir Psychiatr; 1979; 125(2):265-9. PubMed ID: 45343
[TBL] [Abstract][Full Text] [Related]
3. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission.
Georgiev VP; Markovska VL; Petkova BP
Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843
[TBL] [Abstract][Full Text] [Related]
4. GABA receptor agonists and extrapyramidal motor function: therapeutic implications for Parkinson's disease.
Bartholini G; Scatton B; Zivkovic B; Lloyd KG
Adv Neurol; 1987; 45():79-83. PubMed ID: 3030072
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic, GABA-ergic and cholinergic interaction in the regulation of striatal acetylcholine concentration.
Sethy VH
Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):359-62. PubMed ID: 358340
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
Casu M; Gale K
J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
[TBL] [Abstract][Full Text] [Related]
7. Apomorphine stereotypies and transmitter mechanisms in the striatum. II. Interactions between GABA-ergic and cholinergic transmission.
Georgiev VP; Petkova BP
Acta Physiol Pharmacol Bulg; 1978; 4(3):65-70. PubMed ID: 220844
[TBL] [Abstract][Full Text] [Related]
8. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
[No Abstract] [Full Text] [Related]
9. Thalamic regulation of striatal acetylcholine efflux is both direct and indirect and qualitatively altered in the dopamine-depleted striatum.
Zackheim J; Abercrombie ED
Neuroscience; 2005; 131(2):423-36. PubMed ID: 15708484
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics.
Ladinsky H; Consolo S; Samanin R; Algeri S; Ponzio F
Adv Biochem Psychopharmacol; 1980; 24():259-65. PubMed ID: 7405665
[No Abstract] [Full Text] [Related]
11. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of the GABAergic system in dopaminergic-cholinergic interactions in electroacupuncture-induced analgesia.
Chakrabarti S; Ganguly A; Poddar MK
Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):545-9. PubMed ID: 3265752
[TBL] [Abstract][Full Text] [Related]
13. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
DeBoer P; Abercrombie ED
J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
15. gamma-Aminobutyric acid (GABA) receptor stimulation. IV. Effect of progabide (SL 76002) and other GABAergic agents on acetylcholine turnover in rat brain areas.
Scatton B; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):689-95. PubMed ID: 6278131
[No Abstract] [Full Text] [Related]
16. Cortical modulation of striatal function.
Scatton B; Worms P; Lloyd KG; Bartholini G
Brain Res; 1982 Jan; 232(2):331-43. PubMed ID: 6200179
[TBL] [Abstract][Full Text] [Related]
17. Genetics, neuroleptic response and the organization of cholinergic neurons in the mouse striatum.
Dains K; Hitzemann B; Hitzemann R
J Pharmacol Exp Ther; 1996 Dec; 279(3):1430-8. PubMed ID: 8968368
[TBL] [Abstract][Full Text] [Related]
18. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
Kulkarni SK; Bishnoi M; Chopra K
Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
[TBL] [Abstract][Full Text] [Related]
19. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
Lavoute C; Weiss M; Rostain JC
Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
[TBL] [Abstract][Full Text] [Related]
20. Glycine stimulates the release of labeled acetylcholine but not dopamine nor glutamate from superfused rat striatal tissue.
Hernandes MS; de Magalhães L; Troncone LR
Brain Res; 2007 Sep; 1168():32-7. PubMed ID: 17707353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
